Gene: Marc1 (mitochondrial amidoxime reducing component 1) Rattus norvegicus
Analyze
Symbol: Marc1
Name: mitochondrial amidoxime reducing component 1
Description: Predicted to have molybdenum ion binding activity, molybdopterin cofactor binding activity, and nitrate reductase activity; predicted to be involved in nitrate metabolic process and oxidation-reduction process; predicted to localize to the mitochondrion; orthologous to human MARC1 (mitochondrial amidoxime reducing component 1); INTERACTS WITH (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE; 1,2-dimethylhydrazine; 2,3,4,7,8-Pentachlorodibenzofuran.
Type: protein-coding
RefSeq Status: VALIDATED
Also known as: LOC690745; mitochondrial amidoxime-reducing component 1; MOCO sulphurase C-terminal domain containing 1; MOCO sulphurase C-terminal domain containing-like; Mosc1
Orthologs:
Latest Assembly: Rnor_6.0 - RGSC Genome Assembly v6.0
Position:
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Rnor_6.013102,693,679 - 102,724,120 (-)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_5.013107,375,873 - 107,398,500 (-)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.413100,747,272 - 100,806,258 (-)NCBIRGSC3.4rn4RGSC3.4
Celera1395,859,205 - 95,880,141 (-)NCBICelera
Cytogenetic Map13q26NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


Disease Annotations
Gene-Chemical Interaction Annotations
Gene Ontology Annotations
References - curated
References - uncurated

Genomics

Comparative Map Data
Position Markers
QTLs in Region (Rnor_6.0)
miRNA Target Status

Sequence

Nucleotide Sequences
Protein Sequences
Transcriptome
Promoters

Strain Variation

Strain Sequence Variants (Rnor 5.0)

Additional Information

External Database Links
Nomenclature History
 
More on Marc1
Alliance Gene
NCBI Gene
Ensembl Gene
JBrowse: rn5 rn6
NCBI Genome Data Viewer

CRRD Object Information
CRRD ID: 1592219
Created: 2006-11-20
Species: Rattus norvegicus
Last Modified: 2019-04-23
Status: ACTIVE



NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.